Analysis of Allosterism in Functional Assays
- 1 November 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 315 (2) , 740-754
- https://doi.org/10.1124/jpet.105.090886
Abstract
The theoretical basis for analyzing the effects of an allosteric modulator on the response to an agonist is described. The effects of an allosteric modulator on the concentration-response curve to an agonist can be attributed to changes in the observed dissociation constant and intrinsic efficacy of the agonist-receptor complex. Each of these two changes can be represented by a coefficient or factor. It is possible to estimate the ratio of the coefficient of change in agonist efficacy divided by that for the agonist dissociation constant. This ratio is designated as the relative activity (RA) of the agonist in the presence of the allosteric modulator. The RA value can be estimated for each concentration of allosteric modulator by nonlinear regression analysis, regardless of the shape of the concentration-response curve. Regression analysis of the RA values against the concentration of allosteric modulator yields estimates of the dissociation constant (KA) of the allosteric modulator and the maximal RA value. If the concentration-response curve to the agonist obeys a logistic function and the allosteric modulator influences the maximal response, it is possible to distinguish between the maximal change in affinity from that of efficacy. If the agonist concentration-response curve obeys a logistic equation with a Hill slope of 1, the RA values can be estimated easily from the agonist EC50 and Emax values. This analysis illustrates the utility of the RA value in quantifying allosteric effects.Keywords
This publication has 11 references indexed in Scilit:
- Allosteric binding sites on cell-surface receptors: novel targets for drug discoveryNature Reviews Drug Discovery, 2002
- Modeling the Functional Effects of Allosteric Modulators at Pharmacological Receptors: An Extension of the Two-State Model of Receptor ActivationMolecular Pharmacology, 2000
- Quantification of Allosteric Interactions at G Protein Coupled Receptors Using Radioligand Binding AssaysCurrent Protocols in Pharmacology, 2000
- The Ternary Complex ModelPublished by Taylor & Francis ,2000
- ‘Inverse agonists’, cooperativity and drug action at benzodiazepine receptorsTrends in Pharmacological Sciences, 1986
- Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the ratLife Sciences, 1986
- Operational models of pharmacological agonismProceedings of the Royal Society of London. B. Biological Sciences, 1983
- AN ANALYSIS OF FUNCTIONAL ANTAGONISM AND SYNERGISMBritish Journal of Pharmacology, 1981
- THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORSBritish Journal of Pharmacology, 1976
- THE PHARMACOLOGY OF FLAXEDIL, WITH OBSERVATIONS ON CERTAIN ANALOGSAnnals of the New York Academy of Sciences, 1951